SCHEMBL346544

SCHEMBL346544

CC(C)c1cc(C(C)C)c(S(=O)O)c(C(C)C)c1.[NaH]

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
FABP4 P15090 3/20 0.48
FABP3 P05413 2/20 0.48
FABP5 Q01469 1/20 0.47
GABRA1 P14867 4/20 0.45
GABRB2 P47870 2/20 0.45
SOAT2 O75908 1/20 0.33
MYC P01106 1/20 0.33
SOAT1 P35610 1/20 0.33
MAP2K3 P46734 1/20 0.33
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
GAA P10253 1/20 0.32
ALDH1A1 P00352 3/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2C19 P33261 1/20 0.31
GABRB1 P18505 3/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL345363 0.98 FABP4 (0.50) FABP4FABP3FABP5GABRA1GABRB2
Calcium SCHEMBL29853758 0.96 FABP4 (0.48) FABP4FABP3FABP5GABRA1GABRB2
SCHEMBL1021280 0.96 FABP4 (0.48) FABP4FABP3FABP5GABRA1GABRB2
SCHEMBL1033044 0.96 FABP4 (0.48) FABP4FABP3FABP5GABRA1GABRB2
SCHEMBL1022543 0.96 FABP4 (0.48) FABP4FABP3FABP5GABRA1GABRB2
Sulfurous Acid SCHEMBL30356309 0.90 FABP4 (0.44) FABP4FABP3FABP5GABRA1GABRB2
SCHEMBL15741262 0.77 FABP4 (0.50) FABP4FABP3FABP5GABRA1GABRB2
SCHEMBL13970208 0.76 GSR (0.35) CA1CA2
SCHEMBL1021278 0.75 FABP4 (0.44) FABP4FABP3FABP5GABRA1GABRB2
Lithium Ion SCHEMBL1033043 0.75 FABP4 (0.44) FABP4FABP3FABP5GABRA1GABRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 346 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2226060-B1 CEMENT FOR DENTAL APPLICATIONS KURARAY NORITAKE DENTAL INC (JP) 2020-03-04 EP claimed
EP-2409997-B1 REDOX-CURING TYPE COMPOSITION KURARAY NORITAKE DENTAL INC (JP) 2016-11-16 EP claimed
US-8552088-B2 Cement for dental applications KURARAY NORITAKE DENTAL INC. (JP) 2013-10-08 US claimed
US-8545225-B2 Redox-curing type composition KURARAY NORITAKE DENTAL INC. (JP) 2013-10-01 US claimed
EP-2409997-A1 REDOX-CURING TYPE COMPOSITION Kuraray Medical Inc. (JP) 2012-01-25 EP claimed
US-20120016094-A1 REDOX-CURING TYPE COMPOSITION KURARAY MEDICAL INC. (JP) 2012-01-19 US claimed
US-20100267856-A1 CEMENT FOR DENTAL APPLICATIONS KURARAY MEDICAL INC. (JP) 2010-10-21 US claimed
EP-2226060-A1 CEMENT FOR DENTAL APPLICATIONS Kuraray Medical Inc. (JP) 2010-09-08 EP claimed
US-12622847-B2 Organosilicon compound and dental composition containing same KURARAY NORITAKE DENTAL INC. (JP) 2026-05-12 US disclosed
EP-4717249-A1 DENTAL COMPOSITION Shofu Inc. (JP) 2026-04-01 EP disclosed
US-20260083642-A1 DENTAL COMPOSITION SHOFU INC (JP) 2026-03-26 US disclosed
US-20260083644-A1 METHOD FOR PRODUCING DENTAL POLYMERIZABLE COMPOSITION OR DENTAL POLYMERIZABLE COMPOSITION INTERMEDIATE SHOFU INC (JP) 2026-03-26 US disclosed
US-20250381101-A1 HIGHLY FLOWABLE DENTAL CURABLE COMPOSITION SHOFU INC. (JP) 2025-12-18 US disclosed
US-12478562-B2 Dental restoration material composition KURARAY NORITAKE DENTAL INC. (JP) 2025-11-25 US disclosed
CN-1273809-A Binding compsns. KURARAY CO (JP) 2000-11-22 CN disclosed
EP-1051961-A1 Bonding compositions for dental use KURARAY CO., LTD. (JP) 2000-11-15 EP disclosed
CN-1253767-A Adhesive compound for tooth KURARAY CO (JP) 2000-05-24 CN disclosed
US-5486544-A AROMATIC SULFINATE POLYMERIZATION CATALYST KURARAY CO., LTD. (JP) 1996-01-23 US disclosed
EP-0408357-B1 Polymerizable composition KURARAY CO (JP) 1994-06-01 EP disclosed
EP-0408357-A2 Polymerizable composition KURARAY CO., LTD. (JP) 1991-01-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260083644-A1 METHOD FOR PRODUCING DENTAL POLYMERIZABLE COMPOSITION OR DENTAL POLYMERIZABLE COMPOSITION INTERMEDIATE ARCN1, LBR, POLL FABP4 4146/4885FABP3 4644/4885FABP5 4740/4885
US-20250381101-A1 HIGHLY FLOWABLE DENTAL CURABLE COMPOSITION RCC1, H1-0, H1-3 FABP4 4221/4885FABP3 4512/4885FABP5 4520/4885
US-12478562-B2 Dental restoration material composition CAD, MAT2B, RER1 FABP4 3087/4885FABP3 4243/4885FABP5 3635/4885
US-12622847-B2 Organosilicon compound and dental composition containing same MSL1, ITGA1, ITGAL FABP4 4707/4885FABP3 4366/4885FABP5 4441/4885
US-20260083642-A1 DENTAL COMPOSITION TAS2R42, COL2A1, TAS2R1 FABP4 2043/4885FABP3 3561/4885FABP5 3676/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.